This announcement is a separate document:
川宁生物：北京中伦（成都）律师事务所关于伊犁川宁生物技术股份有限公司2023年限制性股票激励计划调整授予价格、第一个归属期归属条件成就暨部分限制性股票作废事项的法律意见书
Chuan Ning Biotech: Legal Opinion of Beijing Zhonglun (Chengdu) Law Firm on the 2023 Restricted Stock Incentive Plan of Yili Chuanning Biotechnology Co., Ltd., the adjustment of grant prices, the achievement of ownership conditions during the first vesting period, and the abolition of some restricted stocks
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated